These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34897494)

  • 1. Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids.
    Yamaguchi R; Tanaka E; Nakajima A; Inoue E; Abe M; Sugano E; Sugitani N; Saka K; Ochiai M; Higuchi Y; Sugimoto N; Ikari K; Yamanaka H; Harigai M
    Mod Rheumatol; 2022 Apr; 32(3):522-527. PubMed ID: 34897494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
    Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
    Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study.
    Harada S; Sakai R; Hirano F; Miyasaka N; Harigai M;
    J Rheumatol; 2017 Jul; 44(7):988-995. PubMed ID: 28412701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
    Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.
    Curtis JR; Xie F; Yun H; Bernatsky S; Winthrop KL
    Ann Rheum Dis; 2016 Oct; 75(10):1843-7. PubMed ID: 27113415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
    Liao TL; Chen YM; Liu HJ; Chen DY
    BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.
    Wolfe F; Michaud K; Chakravarty EF
    Rheumatology (Oxford); 2006 Nov; 45(11):1370-5. PubMed ID: 17003175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
    Nimmrich S; Horneff G
    Rheumatol Int; 2015 Mar; 35(3):465-70. PubMed ID: 25583050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of herpes zoster in Japanese patients with rheumatoid arthritis from 2005 to 2010.
    Nakajima A; Urano W; Inoue E; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2015 Jul; 25(4):558-61. PubMed ID: 25648973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
    Yun H; Xie F; Delzell E; Chen L; Levitan EB; Lewis JD; Saag KG; Beukelman T; Winthrop K; Baddley JW; Curtis JR
    Arthritis Care Res (Hoboken); 2015 May; 67(5):731-6. PubMed ID: 25201241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs.
    Wong SCT; Li IWS; Ng AHY; Lau CS; Chung HY
    Int J Rheum Dis; 2020 Feb; 23(2):189-196. PubMed ID: 31489783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.
    Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
    Arthritis Rheum; 2007 Dec; 57(8):1431-8. PubMed ID: 18050184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study.
    Jeong S; Choi S; Park SM; Kim J; Ghang B; Lee EY
    Arthritis Res Ther; 2022 Jul; 24(1):180. PubMed ID: 35902964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
    Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
    Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients.
    Liao TL; Lin CH; Chen HH; Chen YM; Lin CC; Chen DY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study.
    Veetil BM; Myasoedova E; Matteson EL; Gabriel SE; Green AB; Crowson CS
    Arthritis Care Res (Hoboken); 2013 Jun; 65(6):854-61. PubMed ID: 23281295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids.
    Curtis JR; Xie F; Yang S; Bernatsky S; Chen L; Yun H; Winthrop K
    Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1249-1254. PubMed ID: 30295428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort.
    Sugimoto N; Tanaka E; Inoue E; Abe M; Sugano E; Sugitani N; Saka K; Ochiai M; Higuchi Y; Yamaguchi R; Ikari K; Nakajima A; Yamanaka H; Harigai M
    Mod Rheumatol; 2023 Jul; 33(4):715-722. PubMed ID: 35920098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Mok CC; Ho LY; Tse SM; Chan KL; To CH
    Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.